Glaxo's Emails on Avandia reveal concern 9222/337

据 wsj ,jan 14,2009报导. When a study linking Glaxo-SmithKline PLC's diabetes treatment Avandia to increased heart-attack risk was published in 2007, the pharmaceutical giant publicly responded by denouncing the researcher's conclusions. But internal email indicate some of the company's own scientists were concerned that Glaxo's data were showing the same thing.